| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |